<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0040)http://hazard.com/msds/f2/bwm/bwmhh.html -->
<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=windows-1252">
<META content="MSHTML 6.00.6000.16825" name=GENERATOR></HEAD>
<BODY>BRISTOL-MYERS SQUIBB, PHARMACEUTICAL GROUP -- KENALOG INJECTION (10 OR 40 
MG/ML) -- 6505-01-210-4472 <PRE>=====================  Product Identification  =====================

Product ID:KENALOG INJECTION (10 OR 40 MG/ML)
MSDS Date:12/04/1991
FSC:6505
NIIN:01-210-4472
MSDS Number: BWMHH
=== Responsible Party ===
Company Name:BRISTOL-MYERS SQUIBB, PHARMACEUTICAL GROUP
Box:191
City:NEW BRUNSWICK
State:NJ
ZIP:08903
Country:US
Info Phone Num:908-519-2385
Emergency Phone Num:908-519-2385/800-424-9300(CHEMTREC)
Preparer's Name:DR. E. HAYES
CAGE:BRIST
=== Contractor Identification ===
Company Name:BRISTOL-MYERS SQUIBB PHARMACEUTICAL GROUP
Box:191
City:NEW BRUNSWICK
State:NJ
ZIP:08903
Country:US
Phone:908-519-2385
CAGE:BRIST

=============  Composition/Information on Ingredients  =============

Ingred Name:TRIAMCINOLONE ACETONIDE    40 MG/ML
CAS:76-25-5
RTECS #:TU3920000
Other REC Limits:0.001 MG/M3 (MFR)

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:LD50 (ORAL RAT) IS  UKNOWN
Routes of Entry: Inhalation:NO	Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:THIS FORMULATION CONTAINS
    TRIAMCINOLONE ACETONIDE, A POTENT GLUCOCORTICOID ANTIFLAMMATORY
    DRUG. SHORT TERM EXPOSURE IS NOT LIKELY TO PRODUCE HARMFUL EFFECTS.
    WHEN ADMINISTERED AT THERAPEUTIC DOSES, ES PECIALLY AT HIGH DOSES
    FOR PROLONGED PERIODS, SIDE EFFECTS MAY OCCUR AS DESCRIBED IN
    SYMPTOMS. ALSO SEE PACKAGE INSERT.
Explanation of Carcinogenicity:MANUFACTURER GAVE NO COMMENTS OTHER THAN
    THE ABOVE REFERENCES TO THE THREE LISTINGS.
Effects of Overexposure:INGESTED:MUSCLE WEAKNESS &amp; FATIGUE, CHANGES IN
    BONE MATRIX, HEADACHE, VERTIGO, NERVOUS SYSTEM EFFECTS, SKIN
    CHANGES, HYPERGLYCEMIA, PEPTIC ULCER, CATARACT DEVELOPMENT,
    MENSTRUAL DIFFICULTIES, FLUID &amp;  ELECTROLYTE DISTURBANCES.
    INHALED:NOT AHAZARD. SKIN:ABSORBED THROUGH SKIN. EYE:NO
    INFORMATION.
Medical Cond Aggravated by Exposure:THEREPUTIC DOSES OF GLUCOCORTICOIDS
    MAY AGGRAVATE SYSTEMIC FUNGAL INGECTIONS, TURBERCULOSIS, PEPTIC
    ULCERS, DIABETES MELLITUS AND CERTAIN PSYCHIATRIC CONDITIONS.

=======================  First Aid Measures  =======================

First Aid:EYE:FLUSH W/LARGE AMOUNTS OF WATER FOR 15-20 MIN. SKIN:WASH
    W/SOAP &amp; WATER FOR 15-20 MIN. INGESTION:GET MEDICAL ATTENTION.
    INHALATION:REMOVE TO FRESH AIR; IF DIFFICULTY IN BREATHING
    ACMINISTER OXYGEN.	IF A PERSON IS NOT BREATHING ARTIFICIAL
    RESPIRATION CAN BE ATTEMPTED. GET MEDICAL ATTENTION IMMEDIATELY.

=====================  Fire Fighting Measures  =====================

Flash Point:NOT AVAILABLE
Lower Limits:NOT AVAIL.
Upper Limits:NOT AVAIL.
Extinguishing Media:USE WATER
Fire Fighting Procedures:AS W/ALL FIRES,EVACUATE PERSONNEL TO SAFE
    AREA. WHEN THIS MATERIAL IS INVOLVED IN A FIRE, WEAR SELF-CONTAINED
    BREATHING APPARATUS AND FULL PROTECTIVE CLOTHING.
Unusual Fire/Explosion Hazard:USE WATER TO KEEP FIRE EXPOSED CONTAINERS
    COOL. FIGHT FIRE FROM MAXIMUM SAFE DISTANCE. DIVERT RUNOFF TO A
    SAGE AREA. SEE REACTIVITY DATA.

==================  Accidental Release Measures  ==================

Spill Release Procedures:WEAR SUITABLE PROTECTIVE CLOTHING. ABSORB
    LIQUID ONTO ABSORBENT MATERIAL AND PLACE INTO A CONTAINER FOR
    DISPOSAL. VENTILATE SPILL AREA. CECONTAMINATED AFTER MATERIAL HAS
    BEEN PICKED UP.
Neutralizing Agent:MFR GAVE NO INFORMATION ON MSDS.

======================	Handling and Storage  ======================

Handling and Storage Precautions:STORE AT ROOM TEMPERATURE. AVOID
    FREEZING. PROTECT FROM LIGHT. PERSONS ALLERGIC TO THIS SUBSTANCE
    SHOULD AVOID ALL CONTACT WITH IT.
Other Precautions:NONE

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:MFR GAVE NO INFORMATION ON MSDS.
Ventilation:MFR GAVE NO INFORMATION ON MSDS.
Protective Gloves:IMPERMEABLE
Eye Protection:WEAR EYE PROTECTION
Other Protective Equipment:GOWN.
Work Hygienic Practices:PERSONNEL WHO HANDLE DRUG SUGSTANCES SHOULD
    ACOID CONTACT WITH THESE SUBSTANCES.
Supplemental Safety and Health
THERAPEUTIC AGENTS ARE INTENDED FOR USE UNDER DIRECTION OF A PHYSICIAL
    AND/OR UNDER THE CONDITIONS OF USE DESCRIBED ON THE LABEL.

==================  Physical/Chemical Properties  ==================

HCC:N1
NRC/State Lic Num:NONE
Melt/Freeze Pt:M.P/F.P Text:0F,-18C
Vapor Pres:LIKE H2O
Solubility in Water:MIXES, SUSPENSION
Appearance and Odor:WHITE TO OFF-WHITE AQUEOUS SUSPENSION, ODOR:"NOT
    REMARKABLE"

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
NONE KNOWN
Stability Condition to Avoid:MFR GAVE NO INFORMATION ON MSDS.
Hazardous Decomposition Products:THERMAL DECOMPOSITION OR BURNING MAY
    PRODUCE NOXIOUS PRODUCTS, INCLUDING CO, CO2, HCL, HF.
Conditions to Avoid Polymerization:WILL NOT OCCUR.

====================  Disposal Considerations  ====================

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH ALL LOCAL, STATE
    AND FEDERAL REGULATIONS OR WITH THE REGULATIONS OF THE COUNTRY IN
    WHICH THE MATERIAL IS USED.

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.
</PRE></BODY></HTML>
